ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,201,987 | -43.8% | 197,134 | +7.7% | 0.00% | – |
| Q2 2023 | $3,915,301 | -42.1% | 182,958 | +9.4% | 0.00% | -100.0% |
| Q1 2023 | $6,760,000 | +79937.9% | 167,179 | -7.9% | 0.00% | 0.0% |
| Q4 2022 | $8,446 | -99.9% | 181,539 | +5.2% | 0.00% | 0.0% |
| Q3 2022 | $8,954,000 | +6.6% | 172,623 | -2.8% | 0.00% | 0.0% |
| Q2 2022 | $8,398,000 | +198.3% | 177,654 | +349.1% | 0.00% | – |
| Q1 2022 | $2,815,000 | +1.0% | 39,557 | +6.2% | 0.00% | – |
| Q4 2021 | $2,786,000 | +30.3% | 37,255 | -1.0% | 0.00% | – |
| Q3 2021 | $2,138,000 | +28.1% | 37,631 | -0.8% | 0.00% | – |
| Q2 2021 | $1,669,000 | -13.9% | 37,925 | -3.5% | 0.00% | – |
| Q1 2021 | $1,939,000 | +4.1% | 39,307 | -11.2% | 0.00% | – |
| Q4 2020 | $1,863,000 | -9.3% | 44,253 | -3.5% | 0.00% | – |
| Q3 2020 | $2,055,000 | -13.4% | 45,858 | -3.0% | 0.00% | – |
| Q2 2020 | $2,373,000 | -1.6% | 47,256 | +0.7% | 0.00% | -100.0% |
| Q1 2020 | $2,412,000 | -30.8% | 46,917 | -16.8% | 0.00% | 0.0% |
| Q4 2019 | $3,484,000 | -4.4% | 56,392 | -7.1% | 0.00% | 0.0% |
| Q3 2019 | $3,646,000 | -60.2% | 60,696 | -44.4% | 0.00% | -50.0% |
| Q2 2019 | $9,154,000 | +67.6% | 109,185 | +90.9% | 0.00% | +100.0% |
| Q1 2019 | $5,462,000 | -0.7% | 57,181 | -26.4% | 0.00% | 0.0% |
| Q4 2018 | $5,503,000 | +16.9% | 77,697 | +41.1% | 0.00% | 0.0% |
| Q3 2018 | $4,706,000 | -40.7% | 55,059 | -19.6% | 0.00% | -50.0% |
| Q2 2018 | $7,936,000 | -3.9% | 68,473 | -32.9% | 0.00% | 0.0% |
| Q1 2018 | $8,258,000 | -15.4% | 102,068 | -38.6% | 0.00% | 0.0% |
| Q4 2017 | $9,758,000 | +82.6% | 166,287 | +43.4% | 0.00% | +100.0% |
| Q3 2017 | $5,343,000 | +6.9% | 115,977 | -16.5% | 0.00% | 0.0% |
| Q2 2017 | $4,997,000 | +46.9% | 138,890 | +25.7% | 0.00% | 0.0% |
| Q1 2017 | $3,402,000 | -26.3% | 110,454 | -19.8% | 0.00% | 0.0% |
| Q4 2016 | $4,615,000 | +24.8% | 137,746 | -0.9% | 0.00% | 0.0% |
| Q3 2016 | $3,698,000 | +92350.0% | 138,975 | +73044.7% | 0.00% | – |
| Q2 2016 | $4,000 | -66.7% | 190 | -54.1% | 0.00% | – |
| Q1 2016 | $12,000 | -99.1% | 414 | -99.1% | 0.00% | – |
| Q1 2015 | $1,393,000 | – | 45,508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |